In-source your Precision Medicine program and help keep patients close to home
We work with hospitals and cancer centers to establish a Precision Medicine Program for their oncology practice. With MolecularMatch, you can deliver academic-level medicine so patients stay within your network and close to home.
The MolecularMatch web-based portal, MMPower, can be integrated with your EHR system and provides evidence-based targeted therapy and immunotherapy recommendations and geo-located clinical trial matching for tumor boards. Physicians and Nurse Navigators can consider therapy recommendations and provide clinical trial options to patients at the point of care.
The MolecularMatch difference: Tumor Genomics + Patient Clinical Details
Many factors affect a patient’s eligibility for a trial and likely response to a drug, so MolecularMatch considers more criteria than just tumor biomarkers. Our platform utilizes other clinical information from a patient’s medical records, such as comorbidities, mechanisms of resistance, performance status and Tumor Mutation Burden (TMB) to improve the quality of drug and trial matching.
Match more patients to clinical trials
You can surveil your patient population to improve clinical trial enrollment at your institution by integrating MolecularMatch search capabilities into your EHR. Our metrics indicate that surveillance of an EHR with MolecularMatch technology identifies up to 3-fold more patients potentially eligible for a clinical trial.
MolecularMatch provides a powerful resource for molecular pathologists. Identifying treatment options – particularly trials – is a time-consuming task. The MolecularMatch platform allows our team to efficiently match complex genomic test data to appropriate treatment options in much less time.
Christopher Corless, MD, PhD., Chief Medical Officer of the OHSU Knight Diagnostic Laboratories.